Victoria Brown

Insider Reports History

Entity
Individual
Location
Apellis Pharmaceuticals, Inc., 100 5 Th Avenue, 3 Rd Floor, Waltham, MA
Signature
/s/ David Watson, attorney-in-fact for Victoria Brown
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Victoria Brown:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Program Team Lead Common Stock 23.6K $1.5M $63.69 Jan 20, 2023 Direct

Insider Reports Filed by Victoria Brown

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLS Apellis Pharmaceuticals, Inc. Jan 20, 2023 1 -$73.5K 4 Jan 24, 2023 Program Team Lead
APLS Apellis Pharmaceuticals, Inc. Oct 26, 2022 1 -$7.59K 4 Oct 28, 2022 Program Team Lead
APLS Apellis Pharmaceuticals, Inc. Jun 17, 2022 1 -$121K 4 Jun 22, 2022 Program Team Lead
APLS Apellis Pharmaceuticals, Inc. Mar 25, 2022 1 -$4.04K 4 Mar 29, 2022 Program Team Lead
APLS Apellis Pharmaceuticals, Inc. Feb 10, 2022 1 -$8.25K 4 Feb 14, 2022 Program Team Lead
APLS Apellis Pharmaceuticals, Inc. Jan 28, 2022 1 -$16.7K 4 Feb 1, 2022 Program Team Lead
APLS Apellis Pharmaceuticals, Inc. Jan 21, 2022 2 $0 4 Jan 25, 2022 Program Team Lead
APLS Apellis Pharmaceuticals, Inc. Oct 26, 2021 1 $0 4 Oct 27, 2021 Program Team Lead